biopharma

BUSINESS

Sanofi to buy US biopharma group Blueprint for up to $9.5 billion

By Dominique Patton and Geert De Clercq PARIS (Reuters) -France’s Sanofi has agreed to buy U.S.-based Blueprint Medicines Corporation for…

Read More »
Back to top button